Medications

EU watchdog's rejection of ALS drug angers patients

The European Union drug watchdog's refusal to approve an ALS drug already authorized in North America has been called "an affront" by angry French patients, who say they "don't have time to wait".

Immunology

Screening newborns for deadly immune disease SCID saves lives

Introducing widespread screening of newborns for a deadly disease called severe combined immunodeficiency, or SCID, followed by early treatment boosted the five-year survival rate of children with the disorder from 73% before ...

page 7 from 40